Prostate Cancer
Reviews

Volume 7 Supplement 1
January 2019

Home > Disciplines > Publications > Prostate Cancer Reviews > Volume 7, Year 2019 > Supplement 1, January

CONTENTS

▼

DIAGNOSIS
FOLLOW-UP, QUALITY OF LIFE
INTEGRATIVE MEDICINE
OVERALL MANAGEMENT
TREATMENT

DIAGNOSIS

▲

.

Abrate A, Lughezzani G, Gadda GM, Lista G, Kinzikeeva E, Fossati N, Larcher A, Dell'Oglio P, Mistretta F, Buffi N, Guazzoni G, Lazzeri M.
Clinical use of [-2]proPSA (p2PSA) and its derivatives (%p2PSA and Prostate Health Index) for the detection of prostate cancer: a review of the literature.
Korean J Urol. 2014 Jul;55(7):436-45. doi: 10.4111/kju.2014.55.7.436. Epub 2014 Jul 11.
Source . Similar articles

.

Bernard B, Flaig TW.
Point-Prostate Cancer Genomic Analysis: Routine or Research Only?
Oncology (Williston Park). 2018 Dec 17;32(12):607-9.
Source . Similar articles

.

Egevad L, Delahunt B, Yaxley J, Samaratunga H.
Evolution, controversies and the future of prostate cancer grading.
Pathol Int. 2019 Feb;69(2):55-66. doi: 10.1111/pin.12761. Epub 2019 Jan 29.
Source | Abstract | Similar articles

.

Huang YQ, Sun T, Zhong WD, Wu CL.
Clinical performance of serum [-2]proPSA derivatives, %p2PSA and PHI, in the detection and management of prostate cancer.
Am J Clin Exp Urol. 2014 Dec 25;2(4):343-50. eCollection 2014.
Source . Similar articles

.

Kelly WK, Knudsen KE.
Counterpoint-Prostate Cancer Genomic Analysis: Routine or Research Only?
Oncology (Williston Park). 2018 Dec 17;32(12):607, 630-2.
Source . Similar articles

.

Kozikowski M, Malewski W, Michalak W, Dobruch J.
Clinical utility of MRI in the decision-making process before radical prostatectomy: Systematic review and meta-analysis.
PLoS One. 2019 Jan 7;14(1):e0210194. doi: 10.1371/journal.pone.0210194. eCollection 2019.
Source . Similar articles

.

Moghul M, Somani B, Lane T, Vasdev N, Chaplin B, Peedell C, KandaSwamy GV, Rai BP.
Detection rates of recurrent prostate cancer: ⁶⁸Gallium (Ga)-labelled prostate-specific membrane antigen versus choline PET/CT scans. A systematic review.
Ther Adv Urol. 2019 Jan 8;11:1756287218815793. doi: 10.1177/1756287218815793. eCollection 2019 Jan-Dec.
Source . Similar articles

.

Morigi JJ, Stricker PD, van Leeuwen PJ, Tang R, Ho B, Nguyen Q, Hruby G, Fogarty G, Jagavkar R, Kneebone A, Hickey A, Fanti S, Tarlinton L, Emmett L.
Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy.
J Nucl Med. 2015 Aug;56(8):1185-90. doi: 10.2967/jnumed.115.160382. Epub 2015 Jun 25.
Source . Similar articles

.

Murphy DG, Azad AA, Sandhu S, Violet J, Hofman MS.
Prostate-specific Membrane Antigen Across the Spectrum of Prostate Cancer: Detection, Surgery, and Theranostics.
Eur Urol. 2019 Jan 4. pii: S0302-2838(18)31047-9. doi: 10.1016/j.eururo.2018.12.039. [Epub ahead of print]
Source . Similar articles
Referring to: Heck MM et al, Treatment Outcome, Toxicity, and Predictive Factors for Radioligand Therapy with ¹⁷⁷Lu-PSMA-I&T in Metastatic Castration-resistant Prostate Cancer. Eur Urol. 2018 Nov 22. pii: S0302-2838(18)30873-X. doi: 10.1016/j.eururo.2018.11.016. [Epub ahead of print]. Source . Similar articles

.

Pantel K, Hille C, Scher HI.
Circulating Tumor Cells in Prostate Cancer: From Discovery to Clinical Utility.
Clin Chem. 2019 Jan;65(1):87-99. doi: 10.1373/clinchem.2018.287102.
Source . Similar articles

.

Sanhueza C, Kohli M.
Clinical and Novel Biomarkers in the Management of Prostate Cancer.
Curr Treat Options Oncol. 2018 Feb 8;19(2):8. doi: 10.1007/s11864-018-0527-z.
Source . Similar articles

FOLLOW-UP, QUALITY OF LIFE

▲

.

Ndibe C, Wang CG, Sonpavde G.
Corticosteroids in the management of prostate cancer: a critical review.
Curr Treat Options Oncol. 2015 Feb;16(2):6. doi: 10.1007/s11864-014-0320-6. First Online: 12 March 2015
Source . Similar articles

INTEGRATIVE MEDICINE

▲

.

Abrams DI et al, PDQ Integrative, Alternative, and Complementary Therapies Editorial Board.
Prostate Cancer, Nutrition, and Dietary Supplements (PDQ®): Health Professional Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2019 Jan 14.
Source . Similar articles

OVERALL MANAGEMENT

▲

.

Chiu S, Adcock L.
Magnetic Resonance Imaging for Prostate Assessment: A Review of Clinical and Cost-Effectiveness.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Sep 5.
Source . Similar articles

.

Dong L, Zieren RC, Xue W, de Reijke TM, Pienta KJ.
Metastatic prostate cancer remains incurable, why?
Asian J Urol. 2019 Jan;6(1):26-41. doi: 10.1016/j.ajur.2018.11.005. Epub 2018 Nov 29.
Source . Similar articles

.*

Fletcher RH.
Guideline: Experts recommend against prostate cancer screening with prostate-specific antigen test.
Ann Intern Med. 2019 Jan 15;170(2):JC2. doi: 10.7326/ACPJC-2019-170-2-002.
Source . Similar articles

.

Lancia A, Zilli T, Achard V, Dirix P, Everaerts W, Gomez-Iturriaga A, Ingrosso G, Liefhooghe N, Miralbell R, Siva S, Van der Eecken K, Ost P.
Oligometastatic prostate cancer: The game is afoot.
Cancer Treat Rev. 2019 Feb;73:84-90. doi: 10.1016/j.ctrv.2019.01.005. Epub 2019 Jan 17.
Source . Similar articles

TREATMENT

▲

.

Dellis AE, Papatsoris AG.
Perspectives on the current and emerging chemical androgen receptor antagonists for the treatment of prostate cancer.
Expert Opin Pharmacother. 2019 Feb;20(2):163-172. doi: 10.1080/14656566.2018.1548611. Epub 2018 Nov 21
Source . Similar articles

.

Eggener S.
Focal Therapy for Localized Prostate Cancer.
Rev Urol. 2018;20(4):143-144. doi: 10.3909/riu0823.
Source . Similar articles

.

Fizazi K, Smith MR, Tombal B.
Clinical Development of Darolutamide: A Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer.
Clin Genitourin Cancer. 2018 Oct;16(5):332-340. doi: 10.1016/j.clgc.2018.07.017. Epub 2018 Jul 24.
Source . Similar articles

.

Handy CE, Antonarakis ES.
Sequencing Treatment for Castration-Resistant Prostate Cancer.
Curr Treat Options Oncol. 2016 Dec;17(12):64. Epub 2016 Nov 7.
Source . Similar articles

.

Lepor H, Gold S, Wysock J.
Focal Ablation of Prostate Cancer.
Rev Urol. 2018;20(4):145-157. doi: 10.3909/riu0809.
Source . Similar articles

.

Muggia FM et al, PDQ Adult Treatment Editorial Board.
Prostate Cancer Treatment (PDQ®): Health Professional Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2019 Feb 5.
Source . Similar articles

.

Muggia FM et al, PDQ Adult Treatment Editorial Board.
Prostate Cancer Treatment (PDQ®): Patient Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2019 Jan 10.
Source . Similar articles

.

Purshouse K, Protheroe AS.
Abiraterone acetate in combination with prednisone in the treatment of metastatic hormone-sensitive prostate cancer: clinical evidence and experience.
Ther Adv Urol. 2019 Jan 8;11:1756287218820804. doi: 10.1177/1756287218820804. eCollection 2019 Jan-Dec.
Source . Similar articles

bottom

▲